dc.contributor.author | Kramer-Marek, G | |
dc.contributor.author | Maczynska, J | |
dc.contributor.author | Raes, F | |
dc.contributor.author | Malarz, K | |
dc.contributor.author | Da Pieve, C | |
dc.contributor.author | de Mezer, M | |
dc.contributor.author | Niedbala, M | |
dc.contributor.author | Harrington, KJ | |
dc.contributor.author | Kaspera, W | |
dc.coverage.spatial | Barcelona, SPAIN | en_US |
dc.date.accessioned | 2022-01-31T14:07:59Z | |
dc.date.available | 2022-01-31T14:07:59Z | |
dc.date.issued | 2022-01-21 | |
dc.identifier | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295501238&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9 | en_US |
dc.identifier.citation | ANNALS OF ONCOLOGY, 2019, 30 pp. ? - ? (1) | en_US |
dc.identifier.issn | 0923-7534 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4986 | |
dc.identifier.eissn | 1569-8041 | en_US |
dc.identifier.eissn | 1569-8041 | |
dc.format.extent | ? - ? (1) | en_US |
dc.language | English | en_US |
dc.language.iso | eng | en_US |
dc.publisher | OXFORD UNIV PRESS | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_US |
dc.subject | Science & Technology | en_US |
dc.subject | Life Sciences & Biomedicine | en_US |
dc.subject | Oncology | en_US |
dc.title | Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy | en_US |
dc.type | Other | |
dcterms.dateAccepted | 2021-12-09 | |
rioxxterms.version | VoR | en_US |
rioxxterms.versionofrecord | doi.org/10.1186/s12916-021-02213-z | en_US |
rioxxterms.licenseref.startdate | 2019-10-01 | |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | en_US |
pubs.finish-date | 2019-10-01 | en_US |
pubs.notes | Not known | en_US |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/ImmNet | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Preclinical Molecular Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Preclinical Molecular Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Pre-Clinical MRI | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy | |
pubs.publication-status | Published | en_US |
pubs.start-date | 2019-09-27 | en_US |
pubs.volume | 30 | en_US |
pubs.embargo.terms | Not known | en_US |
icr.researchteam | Preclinical Molecular Imaging | |
icr.researchteam | Pre-Clinical MRI | |
icr.researchteam | Targeted Therapy | |
dc.contributor.icrauthor | Kramer-Marek, Gabriela | |
dc.contributor.icrauthor | Harrington, Kevin | |
dc.contributor.icrauthor | Boult, Jessica | |